The Latest Cardiac and Vascular News
Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure NASDAQ, TSX: NVCN VANCOUVER, Feb. 1, 2018 /PRNewswire/ – Neovasc, Inc. (NVCN) (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve technologies, today announced that the “Institut für das Entgeltsystem im […]
HANGZHOU, China, Feb. 1, 2018 /PRNewswire/ — On January 19, 2018, the global first clinical case of MitralStitch™ mitral valve repair system was completed at Yunnan Fuwai Hospital, China. This operation was jointly performed by the team of Professor Pan Xiangbin and Professor Meng Xu from Beijing Anzhen Hospital under the guidance of Academician Hu Shengshou […]
Company celebrates new design that delivers improved flexibility, clarity and control LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it has achieved CE Mark for its new PureFlexTM line of adult arterial cannulae. Engineered to improve the critical link between the patient and extracorporeal circulation, […]
Lotus Valve to Stay Off the Shelves Through 2018 Patrice Wendling – February 01, 2018, Medscape MARLBOROUGH, MA — The beleaguered Lotus heart valve system is not expected to launch in the US market until 2019, according to Boston Scientific officials. All Lotus valves were voluntarily recalled worldwide in February 2017 because of […]
KardiAssureTM provides doctors with clinical insight to improve patient outcomes and address non-adherence of more than 50 cardiovascular medications NASHVILLE, Tenn.–(BUSINESS WIRE)– Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative testing and consulting services to providers, today launched KardiAssureTM, a first-of-its-kind urinalysis that helps healthcare providers monitor cardiovascular medication […]
Rouen, January 30, 2018 – Robocath, a company that conceives and develops cardiovascular robotic systems for the treatment of vascular diseases, announces today the creation of its medical advisory board, including global experts and recognized leaders in interventional cardiology. This committee will help define the clinical strategy of the company and more […]
SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the FDA has approved an Investigational Device Exemption for the CardiAMP Chronic Myocardial Ischemia (CMI) Trial to treat patients with refractory angina (RA). The CardiAMP Chronic Myocardial Ischemia Trial will be […]
MINNEAPOLIS, Jan. 29, 2018 /PRNewswire/ — Mardil Medical Inc., a privately held, clinical-stage medical device company, announced the appointment of Martin Madden to its Board of Directors. A 30-year veteran of Johnson & Johnson’s Research & Development division, Madden has unparalleled experience in bringing exceptional new products and technologies to the market. […]
DURHAM, N.C.–(BUSINESS WIRE)–Please replace the release dated January 24, 2018, with the following corrected version due to multiple revisions. The corrected release reads: FIRST PATIENT ENROLLED IN TRYTON POST APPROVAL STUDY The only FDA approved device to treat coronary bifurcations Tryton Medical, Inc., the leading developer of stents designed to […]
HOUSTON–(BUSINESS WIRE)– CorInnova, an emerging medical device company developing breakthrough technology for the treatment of Heart Failure, announced today that it has been selected to present at the Society for Thoracic Surgeons (STS) / American Association for Thoracic Surgery (AATS) Tech-Con 2018 event to be held this coming Saturday, Jan. 27, […]
